{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T21:47:59Z","timestamp":1784238479636,"version":"3.55.0"},"reference-count":31,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Pre-eclampsia is an important cause of death and complication for pregnant women and perinatal infant. Low-dose aspirin has been most commonly used to prevent pre-eclampsia in high-risk pregnant women. Recently, heparins have also been used alone or in combination with aspirin to prevent pre-eclampsia. However, the optimal doses and combination therapy of aspirin and heparins are not well established. Therefore, we aim to compare aspirin, heparins and their combination to prevent pre-eclampsia in a network meta-analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>We will search the following electronic databases from the date of database establishment to 8 January 2019: PubMed, Embase, Cochrane Library, Web of Science and ProQuest. We will also search additional studies manually. There will be no restriction on the language of publications. Only randomised clinical trials will be eligible in our network meta-analysis. We will include pregnant women who have been recommended for aspirin according to the standard of the American Congress of Obstetricians and Gynecologists, or were designated as high risk in some recent studies. We will include studies comparing the effects of any single or combination of aspirin and heparins with placebo or observation or another intervention in pregnancy. We will include studies that reported one of the following outcomes: pre-eclampsia, severe pre-eclampsia, preterm delivery, perinatal death and full-term pre-eclampsia with delivery at \u226537 weeks. Traditional pairwise meta-analysis will be performed initially, and then network meta-analysis will be performed using frequency analysis method. Subgroup analyses and sensitivity analyses will be conducted to assess the robustness of the findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>This network meta-analysis does not require ethical certification. An overview and information on the prevention of pre-eclampsia in high-risk pregnant women will be provided by this network meta-analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>PROSPERO registration number<\/jats:title><jats:p>CRD42018084248.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2018-026920","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T13:05:50Z","timestamp":1551099950000},"page":"e026920","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Aspirin and heparin for the prevention of pre-eclampsia: protocol for a systematic review and network meta-analysis"],"prefix":"10.1136","volume":"9","author":[{"given":"Jinzhu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaolu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,2,24]]},"reference":[{"key":"2020050713461060000_9.2.e026920.1","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-015-0615-4"},{"key":"2020050713461060000_9.2.e026920.2","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"ACOG committee opinion no. 743: low-dose aspirin use during pregnancy","volume":"132","author":"Low-dose aspirin use during pregnancy","year":"2018","journal-title":"Obstet Gynecol"},{"key":"2020050713461060000_9.2.e026920.3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.semnephrol.2017.05.011","article-title":"Preeclampsia: pathogenesis, prevention, and long-term complications","volume":"37","author":"Jim","year":"2017","journal-title":"Semin Nephrol"},{"key":"2020050713461060000_9.2.e026920.4","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0823-0"},{"key":"2020050713461060000_9.2.e026920.5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"2020050713461060000_9.2.e026920.6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajog.2016.10.016","article-title":"Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: an individual participant data meta-analysis","volume":"216","author":"Meher","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"2020050713461060000_9.2.e026920.7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"2020050713461060000_9.2.e026920.8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/jch.12541","article-title":"Low-dose aspirin for preventing preeclampsia and its complications: a meta-analysis","volume":"17","author":"Xu","year":"2015","journal-title":"J Clin Hypertens"},{"key":"2020050713461060000_9.2.e026920.9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1471-0528.2012.03493.x","article-title":"Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials","volume":"120","author":"Villa","year":"2013","journal-title":"BJOG"},{"key":"2020050713461060000_9.2.e026920.10","doi-asserted-by":"publisher","DOI":"10.1097\/01.ogx.0000425641.72994.b5"},{"key":"2020050713461060000_9.2.e026920.11","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0140-6736(85)92207-X","article-title":"Prevention of pre-eclampsia by early antiplatelet therapy","volume":"1","author":"Beaufils","year":"1985","journal-title":"Lancet"},{"key":"2020050713461060000_9.2.e026920.12","first-page":"CR132","article-title":"The role of aspirin versus aspirin and heparin in cases of recurrent abortions with raised anticardiolipin antibodies","volume":"12","author":"Goel","year":"2006","journal-title":"Med Sci Monit"},{"key":"2020050713461060000_9.2.e026920.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.03230.x"},{"key":"2020050713461060000_9.2.e026920.14","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-03-0167"},{"key":"2020050713461060000_9.2.e026920.15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1160\/TH10-05-0334","article-title":"Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial","volume":"105","author":"Visser","year":"2011","journal-title":"Thromb Haemost"},{"key":"2020050713461060000_9.2.e026920.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04553.x"},{"key":"2020050713461060000_9.2.e026920.17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-391383"},{"key":"2020050713461060000_9.2.e026920.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60793-5"},{"key":"2020050713461060000_9.2.e026920.19","doi-asserted-by":"publisher","DOI":"10.1097\/GCO.0b013e3282f10e33"},{"key":"2020050713461060000_9.2.e026920.20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejogrb.2018.08.587","article-title":"Assessment of NICE and USPSTF guidelines for identifying women at high risk of pre-eclampsia for tailoring aspirin prophylaxis in pregnancy: an individual participant data meta-analysis","volume":"229","author":"Al-Rubaie","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2020050713461060000_9.2.e026920.21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i1753"},{"key":"2020050713461060000_9.2.e026920.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.08.034"},{"key":"2020050713461060000_9.2.e026920.23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/uog.17399","article-title":"Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation","volume":"49","author":"O\u2019Gorman","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2020050713461060000_9.2.e026920.24"},{"key":"2020050713461060000_9.2.e026920.25","unstructured":"Higgins JPT GS . Cochrane handbook for systematic reviews of interventions Version 5.1.0: The Cochrane Collaboration, 2011."},{"key":"2020050713461060000_9.2.e026920.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.03.016"},{"key":"2020050713461060000_9.2.e026920.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2005.06.006"},{"key":"2020050713461060000_9.2.e026920.28","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1037"},{"key":"2020050713461060000_9.2.e026920.29","doi-asserted-by":"crossref","unstructured":"Huang J , Wang X , Chen X , et al . Perioperative antibiotics to prevent acute endophthalmitis after ophthalmic surgery: a systematic review and meta-analysis. PLoS One 2016;11:e0166141.doi:10.1371\/journal.pone.0166141","DOI":"10.1371\/journal.pone.0166141"},{"key":"2020050713461060000_9.2.e026920.30","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1044"},{"key":"2020050713461060000_9.2.e026920.31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jrsm.57","article-title":"Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions","volume":"3","author":"Chaimani","year":"2012","journal-title":"Res Synth Methods"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-026920","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T01:47:51Z","timestamp":1601084871000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-026920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1136\/bmjopen-2018-026920"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-026920","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}